Open-Label Safety Study of AXS-05 in Subjects With Depression

Completed · Phase 3

Conditions studied: Major Depressive Disorder, Treatment Resistant Depression, Depression

In brief

An open-label, long-term, safety study of AXS-05 in patients with major depressive disorder (MDD), including treatment resistant depression.

Key facts

Study ID
NCT04039022
Run by
Axsome Therapeutics, Inc.
People needed
876
Starts
2019-07-08
Expected to finish
2020-10-23
Last updated by the study team
2022-10-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.